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    Esophageal cancer is the eighth most ordinary cancer and the sixth most common cancer between the 
males and ninth for females in the world; its major and effective treatment is external radiotherapy. This type 
of cancer can be found in different areas of esophagus including cervical, upper, middle and lower 
esophagus. In this treatment, healthy tissues such as the trachea, spine and sternum and even thyroid receive 
dose and it is important that the absorbed doses by these organs be in their tolerance dose levels. We 
measured the surface and depth doses in an anthropomorphic phantom using thermoluminescent dosimeters. 
To do so, a target volume was considered in the phantom as a primary esophageal tumor with margins of 5 
cm in the distal and proximal, and 3 cm in lateral. Phantom was CT planned and treatment was performed 
according to patient treatment. The considered measurement locations were Eye, right and left Parotid, left 
and right Submandibular, left and right Thyroid, Trachea, Manubrium of Sternum and Spine. Our results 
show that in places located further to primary beam such as Thyroid (phase one), Trachea, Spine and 
Sternum, the difference between dose from TPS and TLD measurements is observed. In organs which have 
placed within scattered radiation, the difference is insignificant (P-value≥0.05), although some differences 
might cause by TLD limitations. In conclusion, the TPS calculated and TL measured doses distinguish 
significantly at the spine (depth), trachea (depth) and manubrium of sternum especially in phase 1 which 
might be due to the calculation algorithm used by the planning system which is reliable in homogeneous 
medium, but TL measurements were performed in the heterogeneous anthropomorphic phantom. 
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INTRODUCTION 
      Esophageal cancer is one of the 
gastrointestinal cancers which plays a vital role in 
human life, because it’s the pathway to transfer 
foods. It is the eighth most ordinary cancer in the 
world [1] and the sixth most common cancer 
between the males and ninth for females in the 
world [2]. This cancer happens most often in the 
thorax [1]. Epidemiological studies show that the 
age of 60 or older, is the main risk factor for 
esophageal cancer [3]. It is considered to be one 
of the most important cancers in developing 
countries [4]. There exist several treatments for 
this type of cancer, but among them, the major 
and effective treatment is external radiotherapy 
[5]. This type of cancer can be found in different 
areas of esophagus including: cervical, upper, 
middle and lower esophagus. Although 
radiotherapy is an effective treatment, but if not 
done properly it might bring damages to 
surrounding healthy tissues. In treating this type 
of cancer, healthy tissues such as the trachea, 
spine and sternum and even thyroid are within the 
radiation field and will receive dose, but it is 
important that the absorbed doses by these organs 
be in permissible dose levels and not greater than 
the values specified by treatment planning system 
(TPS). Excessive doses cause problems such as 
dry mouth and salivary and thyroid disorders and 
in addition, it causes respiratory problems and 
burning in the chest. In radiotherapy, the depth 
dose distribution in a phantom which simulates 
 




human body [6-8] must be obtained to assure that 
the prescribed dose is delivered to the target 
volume in the patient. An acceptable phantom 
with similar tissues and anatomy of the body was 
presented by Hasanzadeh et al that is useful for 
internal and surface dosimetry [8]. For dosimetric 
aims we need a suitable dosimeter with 
appropriate size and accuracy. Some dosimeters 
have been reported for in vivo dosimetry such as 
metal oxide semiconductor field effect transistors, 
alanine, plastic scintillators, radiochromic films, 
conventional portal films or electronic portal 
imaging devices and gels [9]. Also calculational 
technique such as: Monte Carlo simulation 
methods, thermoluminescent (TL), diode and 
ionization chamber have wide application in 
dosimetry [10, 11]. Among all of dosimeters, 
thermoluminescent dosimeter (TLD) is acceptable 
for internal measurements because its size permits 
easily fit inside the phantom and could be used 
several times without any damages. 
Thermoluminescent dosimetry is mostly used for 
in vivo dosimetry. TLDs have many advantages; 
the most important features can be noted as their 
tissue equivalency. So given the above mentioned 
reasons and the need to assure the quality control 
programs, we decided to measure the surface and 
depth doses in an anthropomorphic phantom 
using thermoluminescent dosimeters. 
 
MATERIALS AND METHODS  
External Radiation Therapy technique (ERT) 
    The target volume considered in the phantom 
was a primary esophageal tumor with margins of 
5 cm in the distal and proximal, and 3 cm in 
lateral. Phantom was CT planned and treatment 
was performed according to patient treatment; this 
was usually followed by a two-or three-field 
technique over 5–6 weeks. Irradiation was 
performed initially with a dose of 45-50 Gy in 1.8 
or 2 Gy/fraction, 5 days a week, by an anterior 
and posterior port in 25 fractions then one anterior 
and bilateral field with total dose 900 cGy in 1.8-
2 Gy in 5 fractions with 6-25 MV photons [12, 
13]. It is notable that in this treatment, the fields 
covered supraclavicular for treatment of 
supraclavicular nodes [14-16], but lunges were 
shielded with Cerrobend blocks to prevent extra 
doses to them. In phase two, we applied three 
fields, one anterior and bi-oblique. In phase two 
spinal cord was shielded and the dose to the spinal 
cord was kept below 45 Gy [13, 15]. All doses 
were prescribed at the isocentre. 
Calibration of dosimeters 
     The dosimeters used in this study were 
LiF:Mg,Ti (TLD-100) thermoluminescent 
dosimeters that are in the form of square 
(3.1×3.1×0.9 mm) chips (Harshaw, USA). 
Thermoluminescent readouts were performed 
using a commercial TLD reader (Harshaw Model 
3500, USA). Dosimeters were annealed using a 
laboratory oven (Atash 1200 Exiton Crop, Iran). 
The annealing procedure used consists of two 
subsequent annealing: 1 h at 400˚C and 24 h at 
80˚C [9]. To prevent the initial steep dose 
gradient in the depth dose curve, TLD 
measurements were carried out near the depth of 
maximum dose dmax [17].  
Before irradiation, all TLD batches were annealed 
and then irradiated to equal doses and were 
readout; the procedure was repeated two times to 
increase accuracy. Elemental calibration 
coefficients (ECC) for each TLD were determined 
by putting TLDs between the entrance of a 
Perspex phantom and delivering them a dose of 
200 cGy with 6 MV photons which was chosen in 
the linear region of TL response (100 cm Source 
Axis Distance (SAD) ,10×10 cm field size). Then 
the calibration curve of TLDs was obtained by 
exposing TLDs to several doses in Plexiglas 
phantom (depth of 3 cm and distance of 97 cm) 
(Figure 1). 
Phantom structure 
Phantom used in this study was an 
anthropomorphic phantom corresponds to an 
average adult body constructed from natural bone 
and mixture of paraffin wax with NaCl as 
impurity for soft tissue, which effective atomic 
number and electron density were 6.57 and 
3.36×10
23
 electrons/g, respectively. Tissue 
substitute for lungs were two spongy woods with 
similar dimensions and density to lungs. Several 
applicators were provided to locate TLD in 
several depths and an esophageal lumen was 
considered for entrance of esophagus applicator 
[8, 18] (Figure 2).  
 
 













Figure 3. Set up of anthropomorphic phantom on the 
treatment couch and TLDs placed in arbitrary positions 
(Arrow shows the external marker). 
 
 
Phantom dosimetric measurements 
    The phantom was CT-Planned during which 
external markers were placed on its surface to 
avoid any mismatch between planned and 
treated sites. All CT slices were sent to the Core 
Plan TPS (Pars radiotherapy center, Tehran, 
Iran). Target volume was considered as CTV 
with 5 cm distal and proximal and 3 cm lateral 
margins. Phase one was planned with 18 MV 
photons in two parallel opposed field technique 
(anterior and posterior) in which 
supraclavicular nodes were irradiated, too.  
Lungs were blocked with Cerrobend to prevent 
any unnecessary irradiation. The three field 
technique was planned for phase two; it 
composed an anterior and bi-oblique beams. 
After planning each phase, phantom was placed 
on the treatment couch (Fig. 3) and TLDs were 
placed at the pre-selected locations at the 
surface and some depth in the phantom (10 
surfaces and 6 depths). The considered 
locations for TLDs were Eye, right Parotid (skin 
surface &1cm depth), left Parotid (skin surface 
&1 cm depth), left Submandibular, right 
Submandibular, left Thyroid (skin surface & 1 
cm depth), right Thyroid (skin surface & 1 cm 
depth), Trachea (skin surface & 4 cm depth), 
Manubrium of Sternum, Spine (inside the 
phantom & skin surface). 
Each TLD measurement point on a phantom 




    The calibration curve with its linear 
regression equation which relates the collected 
charge in TLDs to radiation absorbed dose is 
brought in Figure 4. Radiation doses received 
by organs at risk and organs near radiation field 
in the phantom were measured with calibrated 
TLDs and are presented in cGy in table 1 & 2. 
In this table, dose obtained from TLDs were 
compared to the doses calculated by the 








Figure 4. Calibration curve for thermoluminescent dosimeters 
 
Table 1. Measured and calculated dose to considered  
organs in phantom (phase one) 
Organ 
Absorbed dose (cGy) 
Measured Calculated 




depth 2.88±0.31 0 
surface 1.2±0.05 0 
Submandibular 5.16±0.15 0 
Thyroid 
depth 34.97±0.76 54 
surface 30.84 ±0.88 20 
Trachea 
depth 173.2±11.93 190 
surface 120.17±0.47 120 
Spine 
depth 126.66±27.33 190 
surface 100.75±30.37 80 
Manubrium of Sternum 104.56±0.7 124.8 
*
 not available from TPS. 
 
Table 2. Measured and calculated dose to considered  
organs in phantom (phase two) 
Organ 
Absorbed dose (cGy) 
Measured Calculated 




depth 4.87±0.01 0 
surface 4.88±0.02 0 
Submandibular 5.22±0.36 0 
Thyroid 
depth 5.64±0.87 9.7 
surface 5.04 ±0.11 5.9 
Trachea 
depth 94.51±8.84 120.4 
surface 41.39±1.58 60 
Spine 
depth 151.62±7.88 166 
surface 37.93±2.5 50 
Manubrium of Sternum 42.38±2.99 33.6 
*
 not available from TPS. 
DISCUSSION 
In this study, the appropriate external 
radiotherapy planning was performed to measure 
the absorbed dose to selected organs and besides 
compare those to values obtained from TPS. We 
used 18 MV photons in this study while some 
studies have suggested 6 MV photons or 6–18 
MV photons [19] or 6– 25 MV [13]. The major 
disadvantage of 6 MV photons is the existence of 
many cold points in the plan that prevents 
delivering a suitable dose to tumor and treatment 
area and also hot points at the surface. According 
to Ahmad et al, in phase one (AP/PA), dmax doses 
(hot spot of 2 cm) for 6 and 18 MV photons are 
110 and 105% respectively and cause hot spots; in 
other words the integral dose to surrounding 
tissue would be less with the 18 MV photons and 
in phase two (AP- LPO, RPO) there was no 
difference between 6 and 18 MV photons [20]. 
Among different types of TLDs such as: 
LiF:Mg,Ti, (TLD-100), LiF:Mg,Cu,P (TLD-
700H), CaF2:Dy (TLD-200), CaF2:Mn Al2O3 
(TLD-500) and CaSO4:Dy (TLD-900), LiF:Mg,Ti 
(TLD-100) was selected because of its tissue 
equivalency, flat energy response and high 
sensitivity which make it suitable for entrance and 
skin surface [21].  
The selection of the above mentioned 
anthropomorphic phantom in this investigation 
(because it similarity in design and material to 
 




human body) helps similar absorption and 
scattering effects to human body [8]. Most of 
phantom dosimetric studies were done with 
PMMA phantoms in which they didn’t consider 
heterogeneities like human body [22, 23].  
There are some differences between results of 
TPS and TLD measurements which might be due 
to the tissue inhomogeneity which has not 
considered in TPS calculation algorithm, but 
existed in phantom. According to the ICRU [7] 
the accuracy in the dose determination should be 
within ± 5%, or even lower, in the conventional 
radiotherapy. Some places such as Trachea, spine 
and sternum are in the treatment field in both 
phases, but thyroid is at the edge of field in phase 
one and received primary radiation but in phase 
two it was out of field and didn’t receive any 
primary photons and it just receives scattered 
radiation. In places that locate further to primary 
beam such as Thyroid (phase one), Trachea, Spine 
and Sternum, the difference between dose from 
TPS and TLD measurements is observed. In 
organs which have placed within scattered 
radiation, the difference is insignificant (P-
value≥0.05), although some differences might 
cause by TLD limitations. According to our 
results, by increasing distance from isocenter or 
treatment area, the dose decrease rapidly. TL 
dosimeters were placed between T2 and T3 for 
spine and in front of T1 and T2 for trachea.  
 
The measured dose at parotid, submandibular glands 
and eye are due to scattered radiation. Our results 
show that there is no difference between depth and 
surface doses in the out of field organs; this is only 
possible the absorbed dose to these organs is due to 
scattered radiation.  
 
CONCLUSION 
    This study showed that the absorbed dose at 
points out of field is due to scattered radiation which 
causes relatively similar depth and surface, but in 
points in field of treatment, there exist primary 
radiation and depth and surface doses are different. 
The TPS calculated and TL measured doses 
distinguish significantly at the spine (depth), trachea 
(depth) and manubrium of sternum especially in 
phase 1. Differences might be due to the calculation 
algorithm used by the planning system which is 
reliable in homogeneous medium, but TL 
measurements were performed in the heterogeneous 
anthropomorphic phantom.  
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